Targeting LIM kinase in cancer and neurofibromatosis

Cell Cycle. 2014;13(9):1360-1. doi: 10.4161/cc.28748. Epub 2014 Apr 3.

Authors

Roni Rak¹, Yoel Kloog¹

Affiliation

¹ Department of Neurobiology; The George S. Wise Faculty of Life Sciences; Tel Aviv University; Tel Aviv, Israel.

No abstract available

Publication types

Editorial

MeSH terms

Animals
Antineoplastic Agents / pharmacokinetics
Benzamides / pharmacology*
Humans
Isoxazoles / pharmacology*
Lim Kinases / antagonists & inhibitors
Lim Kinases / metabolism*
Mice
Neoplasms / drug therapy
Neoplasms / enzymology*
Neoplasms / genetics
Neurofibromatosis 1 / enzymology*
Neurofibromatosis 1 / genetics

Substances

3-methyl-N-(3-((3-(trifluoromethyl)phenyl)carbamoyl)phenyl)isoxazole-5-carboxamide
Antineoplastic Agents
Benzamides
Isoxazoles
Lim Kinases